Results for
EOSWISS PHARMA
Switzerland
We plan and perform your complete process validation. From the first gap analysis and risk management, planning, execution and reporting. We support you with full project management, providing support where needed. You free your ressources for your projects, we take care for validations and all connected activities. You reach your goals safely, quicker and faster.
Request for a quoteEOSWISS PHARMA
Switzerland
We carry out projects quickly and without loss of quality. You have short project durations, thus lower costs and a quick return on investment. Contact us for an initial discussion! Our projects often combine Technical and regulatory issues: •Technology & technology transfer (adapt, improve technologies) •Optimise in production •Quality projects (Quality by Design "QbD", Process Analytical Technology "PAT", test design, validations, qualifications) •Short processing times in administration •Improve the supply chain We optimise supply chains, develop suppliers, um/damit: •"Shorten "Lead Times •the supplier reacts quickly •broaden the supplier base •find new suppliers •Relocate productions We take over technical projects like: •"Scale up" in biotechnology and pharmaceuticals •Model and simulate production steps in biotechnology and pharmaceuticals •Improve production processes (quality, process) •modelling new or modified buildings ("virtual factory") •simulate
Request for a quoteINVITRO-CONNECT GMBH
Switzerland
Testing against enveloped viruses as a replacement for the currently unavailable commercial test strategy against 2019-nCov / SARS-CoV-2 Since the new SARS-CoV-2 virus is one of the enveloped viruses, INVITRO-CONNECT GmbH offers testing of various surfaces and disinfectants against the Vaccinia Ankara Virus (MVA) as a reference virus for enveloped viruses, as well as against the bovine coronavirus , which, like SARS-CoV-2, belongs to the genus Betacoronavirus. In addition to standard tests for surfaces in accordance with ISO 21702 (smooth surfaces) and ISO 18184 (rough surfaces) as well as suspension tests for the disinfectant area (EN ISO 14476/16777), other tests are also offered on request (see below). Named tests are currently the state-of-the-art test methods for testing against 2019-nCov / SARS-CoV-2, as there is currently no specific test procedure against the 2019-nCov / SARS-CoV-2 virus itself. For more information --> contact@invitro-connect.com
Request for a quoteINVITRO-CONNECT GMBH
Switzerland
Microbiological examinations / Microbiological tests against viruses, bacteriophages, bacteria, yeast, molds, mycobacteria and bacterial spores for disinfectants, medical devices, pharmaceutical products and cosmetics Our team of experts supports manufacturers of biocidal and medical products as well as cosmetics and pharmaceuticals scientifically in the context of approval projects. For example, we create safety assessments for cosmetics and biocompatibility assessments for medical devices. Here we focus in particular on infection prevention and wound treatment products. For more information please contact INVITRO-CONNECT GmbH for assistance in developing specialized protocols for your test materials. INVITRO-CONNECT GmbH: Fast Project Execution: personal - competent - reliable --> contact@invitro-connect.com
Request for a quoteDo you sell or make similar products?
Sign up to europages and have your products listed
Results for
At industrie - Import exportNumber of results
4 ProductsCompany type
Category